374 related articles for article (PubMed ID: 12804125)
1. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
3. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
4. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
[TBL] [Abstract][Full Text] [Related]
5. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
[TBL] [Abstract][Full Text] [Related]
6. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
7. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
8. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
12. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
Bukstein OG; Kolko DJ
J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
[TBL] [Abstract][Full Text] [Related]
13. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
14. Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: update 2002.
Rapoport JL; Inoff-Germain G
J Atten Disord; 2002; 6 Suppl 1():S57-60. PubMed ID: 12685519
[TBL] [Abstract][Full Text] [Related]
15. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
Lipkin PH; Butz AM; Cozen MA
J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
Lurie S; O'Quinn A
J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
[TBL] [Abstract][Full Text] [Related]
18. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
19. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
[TBL] [Abstract][Full Text] [Related]
20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
